Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands		3 Months Ended		6 Months Ended
		Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Revenues:
Total revenues		$ 0	$ 5,161	$ 0	$ 5,442
Operating expenses:
Research and development		1,001	2,710	3,727	5,553
General and administrative		1,587	3,431	5,267	7,355
Total operating expenses		2,588	6,141	8,994	12,908
Loss from operations		(2,588)	(980)	(8,994)	(7,466)
Other (expense) income:
Interest income		16	67	64	121
Interest expense		(32)	(21)	(74)	(44)
Change in fair value of rights from Private Placement		0	1,221	(3,832)	1,221
Change in fair value measurement of notes payable		0	(7)	(9)	(13)
Other income (expense), net		(1)	95	(9)	76
Total other (expense) income, net		(17)	1,355	(3,860)	1,361
Net income (loss)		(2,605)	375	(12,854)	(6,105)
Net income (loss) attributable to noncontrolling interest		(1)	(11)	(12)	(40)
Net loss attributable to Kineta, Inc.		$ (2,604)	$ 386	$ (12,842)	$ (6,065)
Net loss per share, basic		$ (0.2)	$ 0.04	$ (1.01)	$ (0.65)
Net loss per share, diluted		$ (0.2)	$ 0.04	$ (1.01)	$ (0.65)
Weighted-average shares outstanding, basic	[1]	13,061	9,939	12,723	9,339
Weighted-average shares outstanding, diluted	[1]	13,061	9,939	12,723	9,339
Licensing revenues [Member]
Revenues:
Total revenues		$ 0	$ 5,000	$ 0	$ 5,000
Collaboration revenue [Member]
Revenues:
Total revenues		$ 0	$ 161	$ 0	$ 442

[1] Included in the denominator were 163,000 and 415,000 weighted-average shares of common stock warrants for the three and six months ended June 30, 2024, respectively, with an exercise price of $0.14. Included in the denominator were 640,000 and 506,000 weighted-average shares of common stock warrants for the three and six months ended June 30, 2023, respectively, with exercise prices that ranged from $0.001 to $0.14